EurekAlert! news release
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study published in Eurosurveillance. While this overall burden represents a decrease from the 2005 to 2015 estimate of 1%, infection rates vary significantly across countries, with the highest estimates found in countries in southern and eastern Europe, and the lowest in northern and western countries.
Read the full news release here.